Outcomes Up for Femtosecond Laser-Assisted Cataract Sx

This article originally appeared here.
Share this content:
Outcomes Up for Femtosecond Laser-Assisted Cataract Sx
Outcomes Up for Femtosecond Laser-Assisted Cataract Sx

MONDAY, Aug. 31, 2015 (HealthDay News) -- Femtosecond laser-assisted cataract surgery (FLACS) is associated with improved outcomes compared with conventional cataract surgery, according to a study published online Aug. 27 in Lasers in Surgery and Medicine.

A-Yong Yu, M.D., Ph.D., from the Eye Hospital of Wenzhou Medical University in China, and colleagues examined the preliminary clinical outcomes of FLACS with a noncontact femtosecond laser system. The prospective study included 25 eyes that underwent FLACS and 29 control eyes that underwent conventional cataract surgery.

The researchers found that the trial group had 51.5 and 65.1 percent reductions in phacoemulsification time and overall energy, respectively, compared with the control group (both P = 0.02). At one and three months, there were significant absolute differences between attempted and achieved capsulorhexis diameter (one month: 192.9 ± 212.0 µm and 626.9 ± 656.6 µm, respectively [P = 0.04]; three months: 256.6 ± 181.9 and 572.1 ± 337.0 µm, respectively [P = 0.03]); the absolute difference between attempted and achieved spherical equivalents at three months was significant (0.16 ± 0.16 D and 0.74 ± 0.65 D, respectively; P < 0.01). There was no significant difference noted in mean corneal endothelial cell loss at one or three months.

"With the noncontact femtosecond laser system, FLACS can significantly improve the accuracy and repeatability of capsulorhexis, reduce the phacoemulsification time and overall energy, and enhance the predictability and stability of postoperative refraction," the authors write.

Abstract
Full Text

Share this content:

is free, fast, and customized just for you!




Already a member?

Sign In Now »

Drug Lookup

Browse drugs by: BrandGenericDisease

More in Home

WHO: Vaccine Hesitancy a Major Global Health Threat

WHO: Vaccine Hesitancy a Major Global Health Threat

Percentage of U.S. children 19 to 35 months who have not been vaccinated has quadrupled since 2001

FDA Down to 5 Weeks of Funding to Review New Drug Applications

FDA Down to 5 Weeks of Funding to ...

Agency cannot accept new fees or applications until the shutdown is over

FDA Approves First Generic Version of Epilepsy Drug Sabril

FDA Approves First Generic Version of Epilepsy Drug ...

Generic equivalents held to same vigorous manufacturing standards as brand-name drugs

is free, fast, and customized just for you!




Already a member?

Sign In Now »